Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONStandard

EYLEA

AFLIBERCEPT

Standard Dose
40MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview EYLEA is listed in Drugs@FDA under application 125387 (BLA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient AFLIBERCEPT Form and strength INJECTABLE; INJECTION - 40MG/ML Sponsor REGENERON PHARMACEUTICALS Submission history Latest submission status date: 2024-10-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview EYLEA is listed in Drugs@FDA under application 125387 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient AFLIBERCEPT Form and strength INJECTABLE; INJECTION - 40MG/ML Sponsor REGENERON PHARMACEUTICALS Submission history Latest submission status date: 2024-10-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.